Drugs / TDV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01728792 | Jan → Nov 2013 | dengue disease | Takeda | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01728792 ↗ |
| Modality | Vaccine | “The vaccine tested in this study was TDV.” NCT01728792 ↗ |
| Route | Subcutaneous | “Takeda's Tetravalent Dengue Vaccine Candidate (TDV), 0.5 mL, subcutaneous (SC) injection, one dose in each arm, Day 0 using a needle/syringe.” NCT01728792 ↗ |